Arkolith/Insider Trading/MLTX/Form 4

Moukheibir Catherine

DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Jul 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 3, 2025Sell(S)24K$48.79$1.1M0
Jul 3, 2025Option exercise(M)24K—$024K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2025Option exercise(M)24K—$022K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-061752) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML